A Randomized Double Blind Phase II Study of Preoperative Celecoxib/Paclitaxel/Carboplatin for Stage IIIA Non-Small Cell Lung Cancer
Phase of Trial: Phase II
Latest Information Update: 28 Jul 2016
At a glance
- Drugs Carboplatin; Celecoxib; Paclitaxel
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 02 Mar 2010 Actual end date (Nov 2006) added as reported by ClinicalTrials.gov.
- 02 Mar 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.